ACT-451840

· Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-451840, covering 2016-08-10 to 2016-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects [Phase 1]